Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Does the Projected Growth of the Gouty Arthritis Market Compare Over the Forecast Period?
In recent times, the gouty arthritis market has witnessed significant growth. The market size is projected to rise from $3.44 billion in 2024 to $3.7 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. The past growth can be credited to factors such as a high incidence of chronic diseases, a surge in alcohol consumption, an expanding elderly population, increased approval of innovative therapies for regeneration, and escalating healthcare costs.
Anticipated robust growth in the gouty arthritis market in the coming years signifies an expansion to $4.9 billion by 2029, fuelled by a compound annual growth rate (CAGR) of 7.2%. Factors contributing to this surge during the prediction period include the enhancement of healthcare facilities, a rise in obesity rates, an uptick in gout occurrences, and heightened public consciousness. The projected period will also witness key trends such as escalating demand for effective treatments, the emergence of regenerative therapies, technological progress, the introduction of new products, and approval from regulatory boards.
What Combination of Drivers Is Leading to Accelerated Growth in the Gouty Arthritis Market?
The rise in obesity rates is anticipated to stimulate the expansion of the gouty arthritis market. Defined as a health condition caused by an excessive accumulation of body fat that could endanger a person’s wellbeing, obesity is often determined by using the body mass index (BMI). The surge in obesity can be attributed to the greater intake of calorific, processed foods and inactive lifestyles. Gouty arthritis is influenced by obesity as it enhances uric acid production and diminishes the body’s ability to flush it out, causing uric acid crystals to amass in the joints. Moreover, the extra body weight exacerbates joint stress, intensifying the inflammation and discomfort related to gout. For example, the World Health Organization reported in March 2022 that 1 billion people, including 650 million adults, 340 million adolescents, and 39 million children, have been identified as obese, and this number is continuously climbing. Additionally, future forecasts suggest that nearly 167 million adults and children will face health issues due to overweight by 2025. Consequently, the mounting prevalence of obesity is fuelling the expansion of the gouty arthritis market.
Get Your Free Sample of the Global Gouty Arthritis Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=16070&type=smp
Who Are the Key Players Steering the Development of the Gouty Arthritis Market?
Major companies operating in the gouty arthritis market are:
• Maplebear Inc.
• Talabat.com
• Grubhub Inc.
• Peapod Digital Labs
• DispatchTrack Inc.
How Are Consumer Trends Shaping the Current and Future Landscape of the Gouty Arthritis Market?
Leading firms within the gouty arthritis market are amplifying their efforts to create innovative products, such as cortrophin gel, aiming to offer more effective and targeted treatments for the ailment. Cortrophin gel, or repository corticotropin injection, is a refined version of the adrenocorticotropic hormone (ACTH). It’s used to manage a variety of inflammatory and autoimmune situations, including gouty arthritis. For example, in October 2023, the Food and Drug Administration granted approval to ANI Pharmaceuticals, a pharmaceutical company based in the US, for a new 1-mL vial size of Purified Cortrophin Gel. This product is designed for the supplementary treatment of certain patients suffering from severe gouty arthritis outbreaks. At present, Cortrophin Gel is the only FDA-approved adrenocorticotropic hormone (ACTH) medication suggested for the treatment of suitable patients with acute gouty arthritis flare-ups.
Get Instant Access to the Global Gouty Arthritis Market Report with Swift Delivery!
https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report
What Are the Core Segments of the Gouty Arthritis Market, and How Do They Contribute to Growth?
The gouty arthritis market covered in this report is segmented –
1) By Type: Acute Gouty Arthritis, Chronic Gouty Arthritis
2) By Treatment: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain Reliever, Corticosteroids, Xanthine Oxidase Inhibitors, Uricosurics, Others Treatments
3) By Diagnosis: Joint Fluid Test, Blood Test, X-Ray Imaging, Ultrasound, Dual Energy Computed Tomography (CT) Scan, Other Diagnosis
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Others Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Acute Gouty Arthritis: Monosodium Urate Crystals-Induced Acute Gout, Acute Gout Attack (Intermittent Flares), Severe Acute Gout With Joint Deformities
2) By Chronic Gouty Arthritis: Tophaceous Gout (Presence Of Uric Acid Deposits), Chronic Gout With Joint Damage, Chronic Gout With Renal Complications, Chronic Gout With Comorbidities (Hypertension, Diabetes)
Which Geographical Regions Are Shaping the Gouty Arthritis Market Growth?
North America was the largest region in the gouty arthritis market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the gouty arthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Characteristics That Define the Gouty Arthritis Market?
Gouty arthritis is a type of inflammatory arthritis characterized by sudden, severe attacks of pain, redness, and swelling in the joints, often the big toe. It is caused by the accumulation of uric acid crystals within the joint, leading to intense inflammation and discomfort. Gout can be managed with medications and lifestyle changes to reduce uric acid levels and prevent future flare-ups.
Browse Through More Similar Reports By The Business Research Company:
Osteoarthritis Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report
Rheumatoid Arthritis Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report
Arthritis Monoclonal Antibodies Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
